Supplemental Evidence and Data Request on Documentation Burden, 70661-70662 [2023-22503]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than October 27, 2023.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, IL 60690–1414. Comments can
also be sent electronically to
Comments.applications@chi.frb.org:
1. George B. Bley II, Palm Harbor,
Florida, individually, and acting in
concert with the Bley Family Control
Group; to retain voting shares of
Petefish, Skiles Bancshares, Inc., and
thereby indirectly retain voting shares of
Petefish, Skiles & Company, both of
Virginia, Illinois.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2023–22582 Filed 10–11–23; 8:45 am]
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than November 13, 2023.
A. Federal Reserve Bank of Kansas
City (Jeffrey Imgarten, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001. Comments
can also be sent electronically to
KCApplicationComments@kc.frb.org:
1. State Holding, Inc., Richmond,
Missouri; to become a bank holding
company by acquiring The State Bank,
Richmond, Missouri.
Board of Governors of the Federal Reserve
System.
Ann Misback,
Secretary of the Board.
[FR Doc. 2023–22590 Filed 10–11–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE P
Agency for Healthcare Research and
Quality
FEDERAL RESERVE SYSTEM
Supplemental Evidence and Data
Request on Documentation Burden
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
AGENCY:
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
VerDate Sep<11>2014
17:34 Oct 11, 2023
Jkt 262001
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submission.
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Documentation Burden, which is
currently being conducted by the
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before November 13, 2023.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions: Mailing Address:
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E53A, Rockville, MD
20857.
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SUMMARY:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
70661
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E77D, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT:
Kelly Carper, Telephone: 301–427–1656
or Email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Documentation Burden.
AHRQ is conducting this review
pursuant to Section 902 of the Public
Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Documentation Burden.
The entire research protocol is available
online at: https://effectivehealthcare.
ahrq.gov/products/documentationburden/protocol.
This is to notify the public that the
EPC Program would find the following
information on Documentation Burden
helpful:
D A list of completed studies that
your organization has sponsored for this
topic. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements, if relevant: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including, if relevant, a study
number, the study period, design,
methodology, indication and diagnosis,
proper use instructions, inclusion and
exclusion criteria, and primary and
secondary outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this topic and an index
E:\FR\FM\12OCN1.SGM
12OCN1
70662
Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices
outlining the relevant information in
each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on topics not included in
the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://www.effectivehealthcare.
ahrq.gov/email-updates.
The review will answer the following
questions. This information is provided
as background. AHRQ is not requesting
that the public provide answers to these
questions.
Guiding Questions
Description/Overview of Measurements
of Documentation Burden
(1) What metrics of documentation
burden that have been developed or
used (including metrics broadly—
quantitative and qualitative)?
(a) For which settings, populations,
and intended uses were the metrics
developed?
(b) How have these metrics been
applied?
(c) Is there published information
available on validity of the metrics?
(d) What are the key strengths and
weaknesses of different metrics that
have been used?
(2) What are the different perspectives
on the appropriateness of different
metrics of documentation burden that
have been applied/proposed (e.g.,
scalability, resource intensiveness to
collect, equitable across populations)?
(3) What are the perceptions of
documentation burden from the
perspective of people in different
clinical roles (e.g., doctor, nurse, etc.)
and patients/caregivers?
Factors Influencing Documentation
Burden
(4) What is the role of patients in
documentation burden?
(5) What is the role of setting (i.e.,
rural vs. urban, hospital, outpatient,
academic institution, etc.) in
documentation burden?
PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTINGS)
PICOTS elements
Inclusion criteria
Population .......................................
Healthcare professionals, including but not limited to: ..........................
• Physicians.
• Nurses.
• Other professionals.
• EHR. ...................................................................................................
• Electronic prescribing.
• Electronic patient portals.
• Computerized physician order entry.
• None ...................................................................................................
Metrics of documentation burden, including but not limited to: ............
• WOW.
• Time on Inbox.
• Time on Encounter Note Documentation.
• Excessive workload.
• Time on EHR.
• Administrative tasks.
• Fragmentation of workflow.
• Physician-patient interaction.
• All .......................................................................................................
• Any clinical settings ...........................................................................
• RCTs. .................................................................................................
• Comparative observational studies.
• Surveys.
• Qualitative studies.
• Mixed-method studies.
• Systematic review or meta-analysis.
• Studies published in English as peer reviewed full-text articles .......
• Published after the year 2000 ...........................................................
Interventions (Exposure) .................
Comparators ....................................
Outcomes ........................................
Timing ..............................................
Settings ...........................................
Study design ...................................
Publications .....................................
Exclusion criteria
• Any healthcare professional
without direct patient contact.
• None.
• None.
• None.
•
•
•
•
•
•
•
•
•
None.
None.
In vitro studies.
Erratum.
Editorials.
Letters.
Case studies/case reports.
Narrative reviews.
Foreign language studies.
• Conference abstracts.
Abbreviations: EHR = electronic health record; RCT = randomized clinical trials; WOW = Work Outside of Work.
ddrumheller on DSK120RN23PROD with NOTICES1
Dated: October 5, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–22503 Filed 10–11–23; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
17:34 Oct 11, 2023
Jkt 262001
PO 00000
Frm 00025
Fmt 4703
Sfmt 9990
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 88, Number 196 (Thursday, October 12, 2023)]
[Notices]
[Pages 70661-70662]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22503]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Documentation Burden
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submission.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Documentation
Burden, which is currently being conducted by the AHRQ's Evidence-based
Practice Centers (EPC) Program. Access to published and unpublished
pertinent scientific information will improve the quality of this
review.
DATES: Submission Deadline on or before November 13, 2023.
ADDRESSES:
Email submissions: [email protected].
Print submissions: Mailing Address: Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville,
MD 20857.
Shipping Address (FedEx, UPS, etc.): Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E77D, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: Kelly Carper, Telephone: 301-427-1656
or Email: [email protected].
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Documentation Burden.
AHRQ is conducting this review pursuant to Section 902 of the Public
Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Documentation Burden. The entire research protocol is
available online at: https://effectivehealthcare.ahrq.gov/products/documentation-burden/protocol.
This is to notify the public that the EPC Program would find the
following information on Documentation Burden helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this topic. In the list, please indicate whether results
are available on ClinicalTrials.gov along with the ClinicalTrials.gov
trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, a summary, including the following elements, if
relevant: study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including, if relevant, a study number, the
study period, design, methodology, indication and diagnosis, proper use
instructions, inclusion and exclusion criteria, and primary and
secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this topic and an index
[[Page 70662]]
outlining the relevant information in each submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; study
types not included in the review; or information on topics not included
in the review cannot be used by the EPC Program. This is a voluntary
request for information, and all costs for complying with this request
must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: https://www.effectivehealthcare.ahrq.gov/email-updates.
The review will answer the following questions. This information is
provided as background. AHRQ is not requesting that the public provide
answers to these questions.
Guiding Questions
Description/Overview of Measurements of Documentation Burden
(1) What metrics of documentation burden that have been developed
or used (including metrics broadly--quantitative and qualitative)?
(a) For which settings, populations, and intended uses were the
metrics developed?
(b) How have these metrics been applied?
(c) Is there published information available on validity of the
metrics?
(d) What are the key strengths and weaknesses of different metrics
that have been used?
(2) What are the different perspectives on the appropriateness of
different metrics of documentation burden that have been applied/
proposed (e.g., scalability, resource intensiveness to collect,
equitable across populations)?
(3) What are the perceptions of documentation burden from the
perspective of people in different clinical roles (e.g., doctor, nurse,
etc.) and patients/caregivers?
Factors Influencing Documentation Burden
(4) What is the role of patients in documentation burden?
(5) What is the role of setting (i.e., rural vs. urban, hospital,
outpatient, academic institution, etc.) in documentation burden?
PICOTS (Populations, Interventions, Comparators, Outcomes, Timing, and
Settings)
------------------------------------------------------------------------
Exclusion
PICOTS elements Inclusion criteria criteria
------------------------------------------------------------------------
Population.................... Healthcare Any
professionals, healthcare
including but not professional
limited to:. without direct
Physicians... patient
Nurses....... contact.
Other
professionals..
Interventions (Exposure)...... EHR.......... None.
Electronic
prescribing..
Electronic
patient portals..
Computerized
physician order
entry..
Comparators................... None......... None.
Outcomes...................... Metrics of None.
documentation burden,
including but not
limited to:.
WOW..........
Time on
Inbox..
Time on
Encounter Note
Documentation..
Excessive
workload..
Time on EHR.
Administrative tasks..
Fragmentation
of workflow..
Physician-
patient interaction..
Timing........................ All.......... None.
Settings...................... Any clinical None.
settings.
Study design.................. RCTs......... In
Comparative vitro studies.
observational
studies.. Erratum.
Surveys......
Qualitative Editorials.
studies..
Mixed-method Letters.
studies.. Case
Systematic studies/case
review or meta- reports.
analysis..
Narrative
reviews.
Publications.................. Studies Foreign
published in English language
as peer reviewed full- studies.
text articles. ................
Published
after the year 2000. Conference
abstracts.
------------------------------------------------------------------------
Abbreviations: EHR = electronic health record; RCT = randomized clinical
trials; WOW = Work Outside of Work.
Dated: October 5, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-22503 Filed 10-11-23; 8:45 am]
BILLING CODE 4160-90-P
